RSV is the main cause of severe respiratory infections in infants and young children in Germany - data from the prospective, multicenter PAPI study 2021–2023
Authors:
Open Access
- 19 February 2025
- journal article
- research article
- Published by Springer Nature in Infection
- Vol. 53 (5) , 1-9
Abstract
Summary: Background: Respiratory syncytial virus (RSV) is one of the main causes of morbidity in infants and young children worldwide. Current data on RSV-associated disease burden in Germany before the introduction of new immunization strategies is lacking. Methods: The PAPI study is a multicenter, prospective surveillance study of lower respiratory tract infections (LRTI) in children aged ≤ 24 months in Germany. Results: Data from 1607 children with LRTI hospitalized in twelve German hospitals between September 2021 and May 2023 were analyzed. Among these children, RSV was the most frequently detected pathogen (57.1%), followed by rhino/entero-, metapneumo- and parainfluenza virus. Children with RSV were significantly younger than those with LRTI of other causes (mean of 5.6 ± SD 6.1 vs. mean of 10.1 ± SD 7.3 months, p < 0.001) and more frequently affected in their first six months of life. RSV positive children were significantly more likely to develop hypoxemia (61.9% vs. 44.3%, p < 0.001) and need for intravenous or enteral fluid supplementation (48.1% vs. 43.1%, p = 0.009; 13.2% vs. 5.9%, p < 0.001) than those without RSV. Conclusion: RSV is the dominant pathogen for LRTI-associated hospitalizations in children ≤ 24 months in Germany and associated with a particularly high need for treatment. The ongoing implemented use of RSV immunization according to current recommendations could lead to significant reduction in early childhood morbidity in Germany.Keywords
Funding Information
- Medizinische Hochschule Hannover (MHH)
This publication has 36 references indexed in Scilit:
- Bronchiolitis: Increased severity in the post‐COVID‐19 eraPediatric Pulmonology, 2024
- Respiratory syncytial virus: can we still believe that after pandemic bronchiolitis is not a critical issue for public health?European Journal of Pediatrics, 2023
- Comparative analysis of RSV-related hospitalisations in children and adults over a 7 year-period before, during and after the COVID-19 pandemicJournal of Clinical Virology, 2023
- RSV causes more severe respiratory illness than influenza in admitted children under 2‐years‐oldPediatric Pulmonology, 2023
- RSV through the COVID‐19 pandemic: Burden, shifting epidemiology, and implications for the futurePediatric Pulmonology, 2023
- High burden of RSV hospitalizations in Germany 2021–2022Infection, 2022
- Evaluating the Individual Healthcare Costs and Burden of Disease Associated with RSV Across Age GroupsPharmacoEconomics, 2022
- The rising of old foes: impact of lockdown periods on “non-SARS-CoV-2” viral respiratory and gastrointestinal infectionsInfection, 2022
- Überwachung von COVID-19 durch Erweiterung der etablierten Surveillance für AtemwegsinfektionenBundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2021
- The burden of seasonal and pandemic influenza in infants and childrenEuropean Journal of Pediatrics, 2013